|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
1997-6-12
|
|
pubmed:abstractText |
Blockade of the platelet glycoprotein IIb/IIIa receptor with abciximab (a monoclonal-antibody Fab fragment directed against the receptor) has been shown to diminish ischemic complications among patients undergoing high-risk coronary angioplasty or directional atherectomy but increases bleeding complications. The widespread applicability of this treatment is unknown, particularly in view of the observed risk of hemorrhage.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0028-4793
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
12
|
|
pubmed:volume |
336
|
|
pubmed:owner |
NLM
|
|
pubmed:pagination |
1689-96
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9182212-Aged,
pubmed-meshheading:9182212-Angioplasty, Balloon, Coronary,
pubmed-meshheading:9182212-Antibodies, Monoclonal,
pubmed-meshheading:9182212-Anticoagulants,
pubmed-meshheading:9182212-Coronary Disease,
pubmed-meshheading:9182212-Double-Blind Method,
pubmed-meshheading:9182212-Female,
pubmed-meshheading:9182212-Hemorrhage,
pubmed-meshheading:9182212-Heparin,
pubmed-meshheading:9182212-Humans,
pubmed-meshheading:9182212-Immunoglobulin Fab Fragments,
pubmed-meshheading:9182212-Male,
pubmed-meshheading:9182212-Middle Aged,
pubmed-meshheading:9182212-Myocardial Infarction,
pubmed-meshheading:9182212-Myocardial Ischemia,
pubmed-meshheading:9182212-Platelet Aggregation Inhibitors,
pubmed-meshheading:9182212-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:9182212-Prospective Studies
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators.
|
|
pubmed:affiliation |
Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
